To include your compound in the COVID-19 Resource Center, submit it here.

Biorex Research and Development Co. RT, CytRx deal

CYTR acquired the clinical and pharmaceutical assets of Biorex for $3 million in cash. The deal brings

Read the full 172 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE